{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:31Z","timestamp":1792787791131,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2016_A106"],"award-info":[{"award-number":["2016_A106"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4ts-Herzzentrum Freiburg - Bad Krozingen GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diet-induced obesity can result in the development of a diverse spectrum of cardiovascular and metabolic diseases, including type 2 diabetes, dyslipidemia, non-alcoholic liver steatosis and atherosclerotic disease. MicroRNAs have been described to be important regulators of metabolism and disease development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the current study, we investigated the effects of ubiquitous miR-100 overexpression on weight gain and the metabolic phenotype in a newly generated transgenic mouse strain under normal chow and high fat diet and used microarray expression analysis to identify new potential target genes of miR-100.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>While transgenic overexpression of miR-100 did not significantly affect weight and metabolism under a normal diet, miR-100 overexpressing mice showed a reduced weight gain under a high fat diet compared to wildtype mice, despite an equal calorie intake. This was accompanied by less visceral and subcutaneous fat development and lover serum LDL cholesterol. In addition, transgenic miR-100 mice were more glucose tolerant and insulin sensitive and demonstrated increased energy expenditure under high fat diet feeding. A comprehensive gene expression profiling revealed the differential expression of several genes involved in lipid storage- and metabolism, among them CD36 and Cyp4A14. Our data showed a direct regulation of CD36 by miR-100, leading to a reduced fatty acid uptake in primary hepatocytes overexpressing miR-100 and the downregulation of several downstream mediators of lipid metabolism such as ACC1, FABP4, FAS and PPAR\u03b3 in the liver.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings demonstrate a protective role of miR-100 in high fat diet induced metabolic syndrome and liver steatosis, partially mediated by the direct repression of CD36 and attenuation of hepatic lipid storage, implicating miR-100 as a possible therapeutic target in liver steatosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-021-00364-6","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T08:03:19Z","timestamp":1630915399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice"],"prefix":"10.1186","volume":"27","author":[{"given":"Christian","family":"Smolka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Schl\u00f6sser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hohnloser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bemtgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"J\u00e4nich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hasselblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Grundmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3287-467X","authenticated-orcid":false,"given":"Franziska","family":"Pankratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"364_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/S2040174421000428","author":"DL Almeida","year":"2021","unstructured":"Almeida DL, et al. Early postnatal overnutrition impairs VO2max gains with moderate exercise and increase post-exercise muscle damage in adult male rats. J Dev Orig Health Dis. 2021. https:\/\/doi.org\/10.1017\/S2040174421000428.","journal-title":"J Dev Orig Health Dis"},{"key":"364_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrendo.2015.25","volume":"11","author":"P Arner","year":"2015","unstructured":"Arner P, Kulyte A. MicroRNA regulatory networks in human adipose tissue and obesity. Nat Rev Endocrinol. 2015;11:276\u201388. https:\/\/doi.org\/10.1038\/nrendo.2015.25.","journal-title":"Nat Rev Endocrinol"},{"key":"364_CR3","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/s00125-015-3691-8","volume":"58","author":"A Bonen","year":"2015","unstructured":"Bonen A, et al. Extremely rapid increase in fatty acid transport and intramyocellular lipid accumulation but markedly delayed insulin resistance after high fat feeding in rats. Diabetologia. 2015;58:2381\u201391. https:\/\/doi.org\/10.1007\/s00125-015-3691-8.","journal-title":"Diabetologia"},{"key":"364_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023937","volume":"6","author":"S Cermelli","year":"2011","unstructured":"Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE. 2011;6: e23937. https:\/\/doi.org\/10.1371\/journal.pone.0023937.","journal-title":"PLoS ONE"},{"key":"364_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034872","volume":"7","author":"DV Chartoumpekis","year":"2012","unstructured":"Chartoumpekis DV, Zaravinos A, Ziros PG, Iskrenova RP, Psyrogiannis AI, Kyriazopoulou VE, Habeos IG. Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS ONE. 2012;7: e34872. https:\/\/doi.org\/10.1371\/journal.pone.0034872.","journal-title":"PLoS ONE"},{"key":"364_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/364784","volume":"2008","author":"A Demers","year":"2008","unstructured":"Demers A, Rodrigue-Way A, Tremblay A. Hexarelin signaling to PPARgamma in metabolic diseases. PPAR Res. 2008;2008: 364784. https:\/\/doi.org\/10.1155\/2008\/364784.","journal-title":"PPAR Res"},{"key":"364_CR7","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1042\/CS20171368","volume":"131","author":"GP Diniz","year":"2017","unstructured":"Diniz GP, et al. Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy. Clin Sci (Lond). 2017;131:2885\u2013900. https:\/\/doi.org\/10.1042\/CS20171368.","journal-title":"Clin Sci (Lond)"},{"key":"364_CR8","doi-asserted-by":"publisher","first-page":"11811","DOI":"10.1016\/S0021-9258(19)50272-1","volume":"268","author":"G Endemann","year":"1993","unstructured":"Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811\u20136.","journal-title":"J Biol Chem"},{"key":"364_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau C, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3:87\u201398. https:\/\/doi.org\/10.1016\/j.cmet.2006.01.005.","journal-title":"Cell Metab"},{"key":"364_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/A:1020515210972","volume":"239","author":"M Febbraio","year":"2002","unstructured":"Febbraio M, Guy E, Coburn C, Knapp FF Jr, Beets AL, Abumrad NA, Silverstein RL. The impact of overexpression and deficiency of fatty acid translocase (FAT)\/CD36. Mol Cell Biochem. 2002;239:193\u20137.","journal-title":"Mol Cell Biochem"},{"key":"364_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92\u2013105. https:\/\/doi.org\/10.1101\/gr.082701.108.","journal-title":"Genome Res"},{"key":"364_CR12","doi-asserted-by":"publisher","first-page":"33652","DOI":"10.1074\/jbc.M110.152090","volume":"285","author":"I Gerin","year":"2010","unstructured":"Gerin I, et al. Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem. 2010;285:33652\u201361. https:\/\/doi.org\/10.1074\/jbc.M110.152090.","journal-title":"J Biol Chem"},{"key":"364_CR13","doi-asserted-by":"publisher","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","volume":"294","author":"D Greco","year":"2008","unstructured":"Greco D, et al. Gene expression in human NAFLD. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1281-1287. https:\/\/doi.org\/10.1152\/ajpgi.00074.2008.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"364_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","volume":"27","author":"A Grimson","year":"2007","unstructured":"Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27:91\u2013105. https:\/\/doi.org\/10.1016\/j.molcel.2007.06.017.","journal-title":"Mol Cell"},{"key":"364_CR15","doi-asserted-by":"publisher","first-page":"E846","DOI":"10.1210\/jc.2010-2701","volume":"96","author":"HM Heneghan","year":"2011","unstructured":"Heneghan HM, Miller N, McAnena OJ, O\u2019Brien T, Kerin MJ. Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab. 2011;96:E846-850. https:\/\/doi.org\/10.1210\/jc.2010-2701.","journal-title":"J Clin Endocrinol Metab"},{"key":"364_CR16","doi-asserted-by":"publisher","first-page":"17321","DOI":"10.1073\/pnas.1008499107","volume":"107","author":"T Horie","year":"2010","unstructured":"Horie T, et al. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA. 2010;107:17321\u20136. https:\/\/doi.org\/10.1073\/pnas.1008499107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"364_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12263-017-0577-z","volume":"12","author":"G Iacomino","year":"2017","unstructured":"Iacomino G, Siani A. Role of microRNAs in obesity and obesity-related diseases. Genes Nutr. 2017;12:23. https:\/\/doi.org\/10.1186\/s12263-017-0577-z.","journal-title":"Genes Nutr"},{"key":"364_CR18","doi-asserted-by":"publisher","first-page":"26761","DOI":"10.1074\/jbc.274.38.26761","volume":"274","author":"A Ibrahimi","year":"1999","unstructured":"Ibrahimi A, et al. Muscle-specific overexpression of FAT\/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem. 1999;274:26761\u20136. https:\/\/doi.org\/10.1074\/jbc.274.38.26761.","journal-title":"J Biol Chem"},{"key":"364_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/2211536607666180531093302","volume":"7","author":"K Jampoka","year":"2018","unstructured":"Jampoka K, Muangpaisarn P, Khongnomnan K, Treeprasertsuk S, Tangkijvanich P, Payungporn S. Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease (NAFLD). Microrna. 2018;7:215\u201322. https:\/\/doi.org\/10.2174\/2211536607666180531093302.","journal-title":"Microrna"},{"key":"364_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051004","author":"S Kiran","year":"2021","unstructured":"Kiran S, Kumar V, Kumar S, Price RL, Singh UP. Adipocyte, immune cells, and miRNA crosstalk: a novel regulator of metabolic dysfunction and obesity. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10051004.","journal-title":"Cells"},{"key":"364_CR21","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.2337\/db07-0907","volume":"56","author":"DP Koonen","year":"2007","unstructured":"Koonen DP, et al. Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes. 2007;56:2863\u201371. https:\/\/doi.org\/10.2337\/db07-0907.","journal-title":"Diabetes"},{"key":"364_CR22","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47:D155\u201362. https:\/\/doi.org\/10.1093\/nar\/gky1141.","journal-title":"Nucleic Acids Res"},{"key":"364_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pathol.2018.09.062","volume":"51","author":"A Langsted","year":"2019","unstructured":"Langsted A, Nordestgaard BG. Nonfasting versus fasting lipid profile for cardiovascular risk prediction. Pathology. 2019;51:131\u201341. https:\/\/doi.org\/10.1016\/j.pathol.2018.09.062.","journal-title":"Pathology"},{"key":"364_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tem.2014.04.001","volume":"25","author":"MI Lefterova","year":"2014","unstructured":"Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. Ppargamma and the Global Map of Adipogenesis and beyond. Trends Endocrinol Metab. 2014;25:293\u2013302. https:\/\/doi.org\/10.1016\/j.tem.2014.04.001.","journal-title":"Trends Endocrinol Metab"},{"key":"364_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320. https:\/\/doi.org\/10.1016\/j.cell.2004.12.035.","journal-title":"Cell"},{"key":"364_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3892\/ijmm.2019.4443","volume":"45","author":"K Li","year":"2020","unstructured":"Li K, Zhao B, Wei D, Wang W, Cui Y, Qian L, Liu G. miR146a improves hepatic lipid and glucose metabolism by targeting MED1. Int J Mol Med. 2020;45:543\u201355. https:\/\/doi.org\/10.3892\/ijmm.2019.4443.","journal-title":"Int J Mol Med"},{"key":"364_CR27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","volume":"69","author":"CH Liu","year":"2018","unstructured":"Liu CH, et al. miRNAs in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2018a;69:1335\u201348. https:\/\/doi.org\/10.1016\/j.jhep.2018.08.008.","journal-title":"J Hepatol"},{"key":"364_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12944-018-0790-9","volume":"17","author":"J Liu","year":"2018","unstructured":"Liu J, et al. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. Lipids Health Dis. 2018b;17:153. https:\/\/doi.org\/10.1186\/s12944-018-0790-9.","journal-title":"Lipids Health Dis"},{"key":"364_CR29","doi-asserted-by":"publisher","first-page":"12228","DOI":"10.1073\/pnas.1005191107","volume":"107","author":"TJ Marquart","year":"2010","unstructured":"Marquart TJ, Allen RM, Ory DS, Baldan A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA. 2010;107:12228\u201332. https:\/\/doi.org\/10.1073\/pnas.1005191107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"364_CR30","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1038\/oby.2009.474","volume":"18","author":"R Martinelli","year":"2010","unstructured":"Martinelli R, et al. miR-519d overexpression is associated with human obesity. Obesity (Silver Spring). 2010;18:2170\u20136. https:\/\/doi.org\/10.1038\/oby.2009.474.","journal-title":"Obesity (Silver Spring)"},{"key":"364_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4149\/BLL_2021_090","volume":"122","author":"V Mikusova","year":"2021","unstructured":"Mikusova V, Mikus J, Grilusova K, Roncakova M, Benko J, Martinka E. Insulin resistance and need for a lifestyle change to eliminate it. Bratisl Lek Listy. 2021;122:567\u201371. https:\/\/doi.org\/10.4149\/BLL_2021_090.","journal-title":"Bratisl Lek Listy"},{"key":"364_CR32","doi-asserted-by":"publisher","first-page":"e72324","DOI":"10.1371\/journal.pone.0072324","volume":"8","author":"AM Miller","year":"2013","unstructured":"Miller AM, et al. MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PLoS ONE. 2013;8:e72324. https:\/\/doi.org\/10.1371\/journal.pone.0072324.","journal-title":"PLoS ONE"},{"key":"364_CR33","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1136\/gut.2010.222844","volume":"60","author":"ME Miquilena-Colina","year":"2011","unstructured":"Miquilena-Colina ME, et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut. 2011;60:1394\u2013402. https:\/\/doi.org\/10.1136\/gut.2010.222844.","journal-title":"Gut"},{"key":"364_CR34","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1126\/science.1189123","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","unstructured":"Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Naar AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010;328:1566\u20139. https:\/\/doi.org\/10.1126\/science.1189123.","journal-title":"Science"},{"key":"364_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009022","volume":"5","author":"FJ Ortega","year":"2010","unstructured":"Ortega FJ, et al. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS ONE. 2010;5: e9022. https:\/\/doi.org\/10.1371\/journal.pone.0009022.","journal-title":"PLoS ONE"},{"key":"364_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/CIRCRESAHA.117.311428","volume":"122","author":"F Pankratz","year":"2018","unstructured":"Pankratz F, et al. MicroRNA-100 suppresses chronic vascular inflammation by stimulation of endothelial autophagy. Circ Res. 2018;122:417\u201332. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311428.","journal-title":"Circ Res"},{"key":"364_CR37","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1053\/j.gastro.2014.06.039","volume":"147","author":"EC Park","year":"2014","unstructured":"Park EC, et al. Inhibition of CYP4A reduces hepatic endoplasmic reticulum stress and features of diabetes in mice. Gastroenterology. 2014;147:860\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2014.06.039.","journal-title":"Gastroenterology"},{"key":"364_CR38","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/en.2005-1132","volume":"147","author":"D Patsouris","year":"2006","unstructured":"Patsouris D, Reddy JK, Muller M, Kersten S. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. Endocrinology. 2006;147:1508\u201316. https:\/\/doi.org\/10.1210\/en.2005-1132.","journal-title":"Endocrinology"},{"key":"364_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.mce.2016.03.010","volume":"427","author":"SL Pek","year":"2016","unstructured":"Pek SL, Sum CF, Lin MX, Cheng AK, Wong MT, Lim SC, Tavintharan S. Circulating and visceral adipose miR-100 is down-regulated in patients with obesity and type 2 diabetes. Mol Cell Endocrinol. 2016;427:112\u201323. https:\/\/doi.org\/10.1016\/j.mce.2016.03.010.","journal-title":"Mol Cell Endocrinol"},{"key":"364_CR40","doi-asserted-by":"publisher","DOI":"10.1042\/CS20210549","author":"O Rivera-Gonzalez","year":"2021","unstructured":"Rivera-Gonzalez O, Wilson NA, Coats LE, Taylor EB, Speed JS. Endothelin receptor antagonism improves glucose handling, dyslipidemia, and adipose tissue inflammation in obese mice. Clin Sci (Lond). 2021. https:\/\/doi.org\/10.1042\/CS20210549.","journal-title":"Clin Sci (Lond)"},{"key":"364_CR41","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1096\/fj.13-240168","volume":"28","author":"A Rodrigue-Way","year":"2014","unstructured":"Rodrigue-Way A, et al. Scavenger receptor CD36 mediates inhibition of cholesterol synthesis via activation of the PPARgamma\/PGC-1alpha pathway and Insig1\/2 expression in hepatocytes. FASEB J. 2014;28:1910\u201323. https:\/\/doi.org\/10.1096\/fj.13-240168.","journal-title":"FASEB J"},{"key":"364_CR42","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrm3313","volume":"13","author":"V Rottiers","year":"2012","unstructured":"Rottiers V, Naar AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239\u201350. https:\/\/doi.org\/10.1038\/nrm3313.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"364_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.18632\/aging.100652","volume":"6","author":"F Sheedfar","year":"2014","unstructured":"Sheedfar F, et al. Increased hepatic CD36 expression with age is associated with enhanced susceptibility to nonalcoholic fatty liver disease. Aging (Albany NY). 2014;6:281\u201395. https:\/\/doi.org\/10.18632\/aging.100652.","journal-title":"Aging (Albany NY)"},{"key":"364_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140989","author":"AK Singh","year":"2021","unstructured":"Singh AK, et al. Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI140989.","journal-title":"J Clin Invest"},{"key":"364_CR45","doi-asserted-by":"publisher","first-page":"19034","DOI":"10.1074\/jbc.M115.640292","volume":"290","author":"P Steneberg","year":"2015","unstructured":"Steneberg P, Sykaras AG, Backlund F, Straseviciene J, Soderstrom I, Edlund H. Hyperinsulinemia enhances hepatic expression of the fatty acid transporter Cd36 and provokes hepatosteatosis and hepatic insulin resistance. J Biol Chem. 2015;290:19034\u201343. https:\/\/doi.org\/10.1074\/jbc.M115.640292.","journal-title":"J Biol Chem"},{"key":"364_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9080156","author":"VL Stevens","year":"2019","unstructured":"Stevens VL, Hoover E, Wang Y, Zanetti KA. Pre-analytical factors that affect metabolite stability in human urine, plasma, and serum: a review. Metabolites. 2019. https:\/\/doi.org\/10.3390\/metabo9080156.","journal-title":"Metabolites"},{"key":"364_CR47","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5222\/MMJ.2021.44270","volume":"36","author":"M Vural Keskinler","year":"2021","unstructured":"Vural Keskinler M, FeyIzoglu G, Yildiz K, Oguz A. The frequency of malnutrition in patients with type 2 diabetes. Medeni Med J. 2021;36:117\u201322. https:\/\/doi.org\/10.5222\/MMJ.2021.44270.","journal-title":"Medeni Med J"},{"key":"364_CR48","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/en.2015-1866","volume":"157","author":"CG Wilson","year":"2016","unstructured":"Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ. Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology. 2016;157:570\u201385. https:\/\/doi.org\/10.1210\/en.2015-1866.","journal-title":"Endocrinology"},{"key":"364_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5114\/ceh.2021.107567","volume":"7","author":"VJH Yao","year":"2021","unstructured":"Yao VJH, Sun M, Rahman AA, Samuel Z, Chan J, Zheng E, Yao AC. Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease. Clin Exp Hepatol. 2021;7:241\u20137. https:\/\/doi.org\/10.5114\/ceh.2021.107567.","journal-title":"Clin Exp Hepatol"},{"key":"364_CR50","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3109\/00498254.2013.797622","volume":"43","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Klaassen CD. Hormonal regulation of Cyp4a isoforms in mouse liver and kidney. Xenobiotica. 2013;43:1055\u201363. https:\/\/doi.org\/10.3109\/00498254.2013.797622.","journal-title":"Xenobiotica"},{"key":"364_CR51","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1073\/pnas.1700172114","volume":"114","author":"X Zhang","year":"2017","unstructured":"Zhang X, et al. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. Proc Natl Acad Sci USA. 2017;114:3181\u20135. https:\/\/doi.org\/10.1073\/pnas.1700172114.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-021-00364-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-021-00364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T08:26:04Z","timestamp":1630916764000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-021-00364-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1186\/s10020-021-00364-6","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}